SCOPUS 정보 검색 플랫폼

Volumn 40, Issue 7, 2000, Pages 701-707

Commentary on the FDA draft guidance for bioequivalence studies for nasal aerosols and nasal sprays for local action: An industry view

(1) Harrison, L I a

a 3M COMPANY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID;

AEROSOL; BIOEQUIVALENCE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FOOD AND DRUG ADMINISTRATION; IN VITRO STUDY; PARTICLE SIZE; PRACTICE GUIDELINE; REVIEW;

EID: 0033637886 PISSN: 00912700 EISSN: None Source Type: Journal
DOI: 10.1177/00912700022009440 Document Type: Review

Times cited : (9)

References (20)

1
- 0002451245
- Rockville, MD: FDA Center for Drug Evaluation and Research
- (1999) Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action Draft Guidance [Online]
- Adams, W.P.¹

2
- 0032712373
- The use of different grades of lactose as a carrier for aerolsolised salbutamol sulphate
- (1999) Internat J Pharmaceut , vol.191 , pp. 1-14
- Larhrib, H.¹ Zeng, X.M.² Martin, G.P.³ Marriott, C.⁴ Pritchard, J.⁵

3
- 0031832036
- Towards meaningful laboratory tests for evaluation of pharmaceutical aerosols
- (1998) J Aerosol Med , vol.11 , Issue.SUPPL. 1
- Clark, A.R.¹ Gonda, I.² Newhouse, M.T.³

4
- 85012558399
- Measurement of particle size characteristics of metered dose inhaler aerosols
- (1991) J Aerosol Med , vol.4 , pp. 251-263
- Dolovich, M.¹

5
- 0021355366
- Cascade impactor method for droplet size characterization of a metered-dose nasal spray
- (1984) J Pharmaceut Sci , vol.73 , pp. 344-348
- Yu, C.D.¹ Jones, R.E.² Henesian, M.³

6
- 0032786652
- Time-to-flight aerodynamic particle size analyzers: Their use and limitations for the evaluation of medical aerosols
- (1999) J Aerosol Med , vol.12 , pp. 217-240
- Mitchell, J.P.¹ Nagel, M.W.²

7
- 0031405180
- Variability in size distribution measurements obtained using multiple Andersen Mark II cascade impactors
- (1997) Pharmaceut Res , vol.14 , pp. 1718-1725
- Stein, S.W.¹ Olson, B.A.²

8
- 0032790249
- Size distribution measurements of metered dose inhalers using Andersen Mark II cascade impactors
- (1999) Internat J Pharmaceut , vol.186 , pp. 43-52
- Stein, S.W.¹

9
- 0027992402
- Regulatory aspects of modifications to innovator bronchodilator metered dose inhalers and development of generic substitutes
- (1994) J Aerosol Med , vol.7 , pp. 119-134
- Adams, W.P.¹ Poochikian, G.² Taylor, A.S.³ Patel, R.M.⁴ Burke, G.P.⁵ Williams, R.L.⁶

10
- 0004234237
- Rockville, MD: FDA Center for Drug Evaluation and Research
- (1997) Modified Release Solid Oral Dose Forms: Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation Guidance for Industry

11
- 0003701605
- Rockville, MD: FDA Center for Drug Evaluation and Research
- (1997) Extended Release Oral Dose Forms: Development, Evaluation, and Applications of In Vitro/In Vivo Correlations

12
- 85037806667
- Rockville, MD: FDA Center for Drug Evaluation and Research
- (2000) CDER Approved Drug Products with Therapeutic Equivalence Indications. Preface to the twentieth edition

13
- 0033062087
- Systemic availability of budesonide after nasal administration of three different formulations: Pressurized aerosol, aqueous pump spray, and powder
- (1999) Br J Clin Pharmacol , vol.47 , pp. 619-624
- Thorsson, L.¹ Borga, O.² Edsbacker, S.³

14
- 0019133975
- Flunisolide: A review of its pharmacological properties and therapeutic efficacy in rhinitis
- (1980) Drugs , vol.19 , pp. 397-411
- Pakes, G.E.¹ Brogden, R.N.² Heel, R.C.³ Speight, T.M.⁴ Avery, G.S.⁵

15
- 0027945805
- Nasal mucosal inflammation has no effect on the absorption of intranasal triamcinolone acetonide
- (1994) J Clin Pharmacol , vol.34 , pp. 854-858
- Argenti, D.¹ Colligon, I.² Heald, D.³ Ziemniak, J.⁴

16
- 85037803626
- High sensitivity HPLC/MS/MS method for the determination of beclomethasone dipropionate and beclomethasone-17-monopropionate in human plasma
- (1996) Pharmaceut Res , vol.13 , Issue.SUPPL.
- Beaudry, F.¹ Hardy, A.² Chilton, A.³ Lessard, D.⁴

17
- 0030827074
- Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity
- (1997) Am J Respir Crit Care Med , vol.156 , pp. 744-751
- Lawrence, M.¹ Wolfe, J.² Webb, D.R.³ Chervinsky, P.⁴ Kellerman, D.⁵ Schaumberg, J.P.⁶ Shah, T.⁷

18
- 0029893723
- Fluticasone propionate: Topical or systemic effects?
- (1996) Cline Exp Allergy , vol.26 , Issue.SUPPL. 3 , pp. 18-22
- Howland, W.C.¹

19
- 4243383452
- Lung deposition and basic pharmacokinetic parameters of beclomethasone dipropionate in asthmatic children after inhalation from a HFA p-MDI (Autohaler) and a CFC p-MDI with spacer
- (1999) Am J Respir Crit Care Med , vol.159
- Agertoft, A.¹ Pedersen, S.² Harrison, L.I.³

20
- 0031959073
- Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity
- (1998) J Allergy Clin Immunol , vol.101 , pp. 470-474
- Wilson, A.M.¹ McFarlane, L.C.² Lipworth, B.J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.